Evidence map›Paper›PMID 42106708›Full record

ArticleCell communication and signaling : CCS2026

Neuroinflammation-induced downregulation of RAB7 in murine astrocytes disrupts endo-lysosomal homeostasis and induces astrogliosis.

Jorge Díaz, Samuel Martínez-Meza, María Fernanda González, Esteban Palacios, Andrea Tapia-Bustos, Mario Herrera-Marschitz, Paola Morales, Tomás Monteverde, Gabriel Díaz-Serrano, Ignacio Leyton-Rivera and 7 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jorge DíazCell Communication Laboratory, Núcleo Interdisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile.ORCID http://orcid.org/0000-0002-0830-6122
Samuel Martínez-MezaCell Communication Laboratory, Núcleo Interdisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile.
María Fernanda GonzálezCell Communication Laboratory, Núcleo Interdisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile.
Esteban PalaciosCell Communication Laboratory, Núcleo Interdisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile.
Andrea Tapia-BustosNúcleo Interdisciplinario de Farmacología e Inmunología, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile.
Mario Herrera-MarschitzNúcleo Interdisciplinario de Farmacología e Inmunología, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile.
Paola MoralesNúcleo Interdisciplinario de Farmacología e Inmunología, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile.
Tomás MonteverdeCell Communication Laboratory, Núcleo Interdisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile.
Gabriel Díaz-SerranoCell Communication Laboratory, Núcleo Interdisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile.
Ignacio Leyton-RiveraCell Communication Laboratory, Núcleo Interdisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile.
Alejandro ChamorroCell Communication Laboratory, Núcleo Interdisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile.
Ignacio A WichmannDepartment of Obstetrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, 8330034, Chile.
Rocío ArtigasDepartamento de Hematología y Oncología, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, 8330034, Chile.
Alejandro CorvalánDepartamento de Hematología y Oncología, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, 8330034, Chile.
Andrew F G QuestCell Communication Laboratory, Núcleo Interdisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile.ORCID http://orcid.org/0000-0001-8755-1590
Horacio MaldonadoCell Communication Laboratory, Núcleo Interdisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile. Horacio.maldonado@umayor.cl.ORCID http://orcid.org/0000-0002-7017-5215
Lisette LeytonCell Communication Laboratory, Núcleo Interdisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, 8380453, Chile. lleyton@uchile.cl.ORCID http://orcid.org/0000-0001-9690-9638

Funding

Agencia Nacional de Investigación y Desarrollo BECAS/DOCTORADO NACIONAL #21252379 (IL-R)Agencia Nacional de Investigación y Desarrollo CONICYT-FONDAP #15130011, Continuation #1523A0008 (AFGQ; AC)Agencia Nacional de Investigación y Desarrollo FONDECYT/POSTDOCTORADO NACIONAL #3170169 (JD)Agencia Nacional de Investigación y Desarrollo FONDECYT/POSTDOCTORADO NACIONAL #3230227Agencia Nacional de Investigación y Desarrollo FONDECYT/PROYECTO REGULAR #1200836 & #1240888 (LL)Agencia Nacional de Investigación y Desarrollo FONDECYT/PROYECTO REGULAR #1231443 (MH-M)Instituto de Ciencias Biomédicas, Facultad de Medicina, University of Chile ICBM #57419Universidad de Talca BECAS/DOCTORADO ESTUDIANTES EXTRANJEROS #FCS-DC-001 (GD-S)
6 · The paper itself

Abstract

backgroundNeuroinflammation induces astrogliosis, a process marked by astrocyte hypertrophy, increased migration, and altered protein expression. While these changes involve both up- and downregulation of specific genes, the mechanisms governing protein turnover-particularly degradation-remain poorly understood. Here, we investigated how astrocyte endo-lysosomal function is altered during inflammation and explored the role of key regulators such as RAB7 in this response.

methodsWe analyzed gene expression datasets from an optic nerve injury model to identify pathways associated with reactive gliosis. RAB7 expression and astrocyte reactivity markers, including β3 integrin and GFAP, were assessed in a postnatal rat model of brain injury to evaluate glial responses during early brain maturation. In vitro, TNF-treated astrocytes were used to evaluate changes in gene and protein expression, RAB GTPase activity, lysosomal function, migration, and reactivity markers. RAB7 was overexpressed in selected experiments to confirm its role. The effects of reactive astrocytes on neurite outgrowth were assessed using co-culture assays.

resultsIn silico analysis revealed an alteration in the endo-lysosomal pathway under inflammatory conditions. Consistently, downregulation of active and total RAB7, along with GFAP and β3 integrin upregulation, were observed in TNF-treated astrocytes and in the in vivo injury model. Reduced RAB7 was associated with impaired lysosomal function, enhanced astrocyte migration, and reduced neurite outgrowth in neurons co-cultured with reactive astrocytes. Overexpression of RAB7 protected cells from the effects of inflammation, preventing TNF-induced impairment of lysosomal function, astrocyte migration, and neurite outgrowth.

conclusionsOur results suggest that inflammation downregulates RAB7, resulting in the appearance of various traits associated with astrocyte reactivity, such as elevated β3 Integrin and GFAP levels. Moreover, RAB7 overexpression prevents these changes. These findings identify RAB7 as a key regulator of astrogliosis and reveal a mechanistic link between RAB-dependent endo-lysosomal pathways and astrocyte reactivity under inflammatory conditions.

Indexed as

AstrocytesDown-RegulationEndosomesGliosisHomeostasisLysosomesNeuroinflammatory Diseasesrab GTP-Binding ProteinsAnimalsCell MovementCells, CulturedMicerab7 GTP-Binding ProteinsRatsrab7 GTP-Binding Proteinsrab7 GTP-binding proteins, mouserab7 GTP-binding proteins, ratrab GTP-Binding ProteinsCell migrationEndosome–lysosome pathwayGlial cellsLysosomeNeurite outgrowthNeuroinflammationRAB7 GTPaseReactive astrocytes

Identifiers

PMID42106708
PMCPMC13418144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.